Trademark Overview
On Friday, January 9, 2026, a trademark application was filed for NEXOPLEX BIO with the United States Patent and Trademark Office. The USPTO has given the NEXOPLEX BIO trademark a serial number of 99585846. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, January 9, 2026. This trademark is owned by Gritstone bio, Inc.. The NEXOPLEX BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical products development; Pharmaceutical product evaluation; Pharmaceutical research and development; Scientific research for medical purposes in the area of cancerous diseases; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies; Development of new technology for others in the field of cancer immunotherapy platforms for manufacturing therapeutics; Scientific and technological services, namely, scientific research of specific molecular and genomic data for analytical and clinical purposes in the field of treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
